Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-185,145
Closed -$7.88M 70
2017
Q1
$7.88M Buy
+185,145
New +$7.55M 2.14% 11
2014
Q2
Sell
-84,837
Closed -$1.82M 68
2014
Q1
$1.82M Buy
84,837
+4,428
+6% +$95.5K 0.65% 49
2013
Q4
$1.8M Buy
80,409
+4,923
+7% +$109K 0.68% 47
2013
Q3
$1.56M Buy
75,486
+4,278
+6% +$91.1K 0.63% 49
2013
Q2
$1.37M Buy
+71,208
New +$1.49M 0.61% 49

Other funds holding HOLX

Evanston Advisors's HOLX Position: Q2 2017 in Review

Evanston Advisors sold out of Hologic (HOLX) in Q2 2017, closing a stake of 185,145 shares — an estimated $7.88M sold.

Evanston Advisors first reported a position in HOLX in Q2 2013 and held it in 5 quarters. The position peaked at $7.88M in Q1 2017. 505 funds tracked by Wall St. Rank hold HOLX as of Q2 2017.

  • Evanston Advisors reported no remaining Hologic position as of Q2 2017 after selling out during the quarter.
  • Evanston Advisors sold 185,145 Hologic shares in Q2 2017, an estimated $7.88M.
  • Evanston Advisors first reported a position in Hologic in Q2 2013 and held it in 5 quarters.
  • Evanston Advisors's Hologic position peaked at $7.88M in Q1 2017.
  • 505 funds tracked by Wall St. Rank held Hologic as of Q2 2017.

Based on Evanston Advisors's 13F filing for Q2 2017, filed 9 Aug 2017.